After-Hours Stock Movers 01/16: (JUNO) (NEWA) (VRS) Higher; (ATEN) (HIVE) (OBLN) Lower (more...)

January 16, 2018 6:12 PM

Today's After-Hours Movers

Juno Therapeutics (NASDAQ: JUNO) 44.4% HIGHER; Celgene (NASDAQ: CELG) is in Talks to Buy Juno - WSJ

Newater Technology, Inc. (NASDAQ: NEWA) 26.1% HIGHER; announce its new strategic partnership with NW Blockchain Limited ("NWBL"), a blockchain developer focused upon environmental protection projects, to jointly develop blockchain applications to use in the wastewater treatment industry.

A10 Networks, Inc. (NYSE: ATEN) 21.4% LOWER; A10 Networks expects total revenue in the fourth quarter 2017 to be between $55.5 million and $56.0 million, below its prior guidance of $64.0 million to $67.0 million. The company expects to report GAAP net income in the range of break-even to $0.01 per share. On a non-GAAP basis, the company expects to report net income between $0.05 and $0.06 per share, using approximately 74.6 million diluted shares, which is within the previous guidance for non-GAAP net income of $0.01 to $0.07 per share, using approximately 74.0 million shares on a diluted basis. GAAP and non-GAAP net income results include a benefit from performance-based variable compensation. A preliminary reconciliation between GAAP and non-GAAP information is contained in the financial statements below. (Street sees Q4 EPS of 3c on revenue of $65.1 million).

Aerohive Networks (NYSE: HIVE) 18.6% LOWER; announced preliminary results for the fourth quarter ended December 31, 2017. Aerohive® expects net revenue for the fourth quarter to be approximately $37 million, which is below the Company's previously stated guidance of $40 million to $42 million.

Obalon Therapeutics, Inc. (NASDAQ: OBLN) 11.7% LOWER; announced that it is commencing an underwritten public offering of $35 million of shares of its common stock. Obalon Therapeutics also expects to grant the underwriters a 30-day option to purchase up to an additional $5.25 million of shares of its common stock. The offering is subject to market and other conditions and there can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares are being offered by Obalon Therapeutics.

Verso Corporation (NYSE: VRS) 10.3% HIGHER; announced today that the Strategic Alternatives Committee formed by its Board of Directors in September 2017, has, at the direction of the Board, expanded its evaluation of potential transaction alternatives to include other alternatives, including but not limited to, a potential sale or merger of the entire company.

bluebird bio (NASDAQ: BLUE) 7.6% HIGHER; gains amid reports Celgene is in Talks to Buy Juno

Intrexon Corporation (NYSE: XON) 6.3% LOWER; announced today it has commenced an underwritten public offering of shares of its common stock. In addition, Intrexon intends to grant the underwriters a 30-day option to purchase additional shares of its common stock. The offering is subject to market and other conditions and there can be no assurances as to whether or when the offering may be completed, or as to the size or terms of the offering.

Bellicum Pharmaceuticals (NASDAQ: BLCM) 5.8% HIGHER; gains amid reports Celgene is in Talks to Buy Juno

Adient, plc (NYSE: ADNT) 5% LOWER; Adient and Boeing (NYSE: BA) today announced the formation of Adient Aerospace, a joint venture that will develop, manufacture, and sell a portfolio of seating products to airlines and aircraft leasing companies. The seats will be available for installation on new airplanes and as retrofit configurations for aircraft produced by Boeing and other commercial airplane manufacturers.

Boot Barn Holdings, Inc. (NYSE: BOOT) 4.5% LOWER; announced the launch of a public offering of 5,500,000 shares of its common stock held by certain of its stockholders. The selling stockholders include funds managed by Freeman Spogli & Co., offering approximately 5,100,000 shares, and certain directors and members of management, offering approximately 400,000 shares (collectively the selling stockholders). The underwriters will have a 30-day option to purchase up to an additional 825,000 shares from the selling stockholders on a pro rata basis. The Company will not issue shares in the offering and will not receive any proceeds from the sale of the shares by the selling stockholders in this offering.

Interactive Brokers (NASDAQ: IBKR) 2.3% LOWER; reported Q4 EPS of ($0.02), versus $0.40 reported last year. Revenue for the quarter came in at $593 million versus the consensus estimate of $398.41 million.

Celgene (NASDAQ: CELG) 2% LOWER; Celgene is in Talks to Buy Juno - WSJ

Categories

Special Reports

Next Articles